About 37 million American adults suffer from overactive bladder, while nearly 20 million experience fecal incontinence. For more than 20 years, patients have been receiving symptom relief using the InterStim™ from Medtronic, but the company sought technology that would offer a more discreet and user-friendly way to put control of the therapy in the patient's hands. Through collaboration with Samsung, Medtronic developed a new InterStim™ smart programmer using a Galaxy smartphone and therapy applications. The smartphone is preloaded with Medtronic proprietary software applications that let patients discreetly manage their treatment.
Kirstie, an InterStim™ patient, had struggled with fecal incontinence for over 10 years before receiving sacral neuromodulation. "[InterStim™ has] been a godsend. It allows me to start living my life again, get out of the house more, go out to dinner with my family."
Read the full case study on the development of Medtronic’s smartphone-based programmer for incontinence treatment: insights.samsu...
Learn more about how Medtronic is transforming healthcare: www.medtronic....
ID number - UC202007727 EN
29 авг 2024
